GB1107935A

GB1107935A – A 7-chloro-4-aminoalkylaminoquinoline, its preparation and pharmaceutical compositions
– Google Patents

GB1107935A – A 7-chloro-4-aminoalkylaminoquinoline, its preparation and pharmaceutical compositions
– Google Patents
A 7-chloro-4-aminoalkylaminoquinoline, its preparation and pharmaceutical compositions

Info

Publication number
GB1107935A

GB1107935A
GB20524/66A
GB2052466A
GB1107935A
GB 1107935 A
GB1107935 A
GB 1107935A
GB 20524/66 A
GB20524/66 A
GB 20524/66A
GB 2052466 A
GB2052466 A
GB 2052466A
GB 1107935 A
GB1107935 A
GB 1107935A
Authority
GB
United Kingdom
Prior art keywords
chloro
quinoline
acid
methylbutylamino
hydroxyethylamino
Prior art date
1965-05-18
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Expired

Application number
GB20524/66A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

STWB Inc

Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1965-05-18
Filing date
1966-05-09
Publication date
1968-03-27

1966-05-09
Application filed by Sterling Drug Inc
filed
Critical
Sterling Drug Inc

1968-03-27
Publication of GB1107935A
publication
Critical
patent/GB1107935A/en

Status
Expired
legal-status
Critical
Current

Links

Espacenet

Global Dossier

Discuss

Classifications

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07D—HETEROCYCLIC COMPOUNDS

C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom

C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

C07D215/38—Nitrogen atoms

C07D215/42—Nitrogen atoms attached in position 4

C07D215/46—Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms

Abstract

7 – Chloro – 4 – [4 – (2 – hydroxyethylamino) – 1 – methylbutylamino] quinoline or an acid addition salt thereof is made by reacting a 7 – chloro – 4 – (4 – halo – 1 – methylbutylamino)-quinoline with 2-hydroxyethylamine and, if desired, reacting the free base obtained with an acid to form a salt. Specified salts include those of oxalic, pamoic, phosphoric, sulphuric, methanesulphonic, 3 – hydroxy – 2 – naphthoic, naponic, salicylic, mucic and muconic acids.ALSO:Anti-inflammatory compositions comprise 7 – chloro – 4 – [4 – (2 – hydroxyethylamino) – 1-methyl-butylamino] quinoline or an acid addition salt thereof and a pharmaceutical carrier. Optional additional ingredients are the corticosteroids, e.g. prednisone, prednisolone, cortisone, hydrocortisone and the 9- or 12-halocorticosteroids; or non-steroids, e.g. acetylsalicylic acid, salicylamide, aminopyrine, chloroquine and hydroxychloroquine. The compositions may be formulated in dosage units for oral or parenteral administration.

GB20524/66A
1965-05-18
1966-05-09
A 7-chloro-4-aminoalkylaminoquinoline, its preparation and pharmaceutical compositions

Expired

GB1107935A
(en)

Applications Claiming Priority (1)

Application Number
Priority Date
Filing Date
Title

US456810A

US3415932A
(en)

1965-05-18
1965-05-18
7 – chloro – 4 – [4-(2-hydroxyethylamino)-1-methylbutylamino]quinoline; anti-inflammatory compositions and method using same

Publications (1)

Publication Number
Publication Date

GB1107935A
true

GB1107935A
(en)

1968-03-27

Family
ID=23814240
Family Applications (1)

Application Number
Title
Priority Date
Filing Date

GB20524/66A
Expired

GB1107935A
(en)

1965-05-18
1966-05-09
A 7-chloro-4-aminoalkylaminoquinoline, its preparation and pharmaceutical compositions

Country Status (11)

Country
Link

US
(1)

US3415932A
(en)

AT
(1)

AT265272B
(en)

BE
(1)

BE681170A
(en)

BR
(1)

BR6679514D0
(en)

CH
(1)

CH471785A
(en)

DE
(1)

DE1620489A1
(en)

FR
(1)

FR5494M
(en)

GB
(1)

GB1107935A
(en)

MY
(1)

MY7000048A
(en)

NL
(1)

NL6606704A
(en)

NO
(1)

NO118153B
(en)

Cited By (1)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

RU2580656C1
(en)

*

2014-11-20
2016-04-10
Закрытое Акционерное Общество “БИОКОМ”
Immediate-release solid dosage form of hydroxychloroquine and method for producing it

Families Citing this family (1)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

EP2967062A4
(en)

2013-03-15
2016-10-19
Univ Leland Stanford Junior
Desethylhydroxychloroquine for the treatment of diseases associated with inflammation

Family Cites Families (1)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

US2546658A
(en)

*

1949-07-23
1951-03-27
Sterling Drug Inc
7-chloro-4-[5-(n-ethyl-n-2-hydroxyethylamino)-2-pentyl] aminoquinoline, its acid addition salts, and method of preparation

1965

1965-05-18
US
US456810A
patent/US3415932A/en
not_active
Expired – Lifetime

1966

1966-05-09
GB
GB20524/66A
patent/GB1107935A/en
not_active
Expired

1966-05-16
NL
NL6606704A
patent/NL6606704A/xx
unknown

1966-05-16
FR
FR61701A
patent/FR5494M/fr
not_active
Expired

1966-05-16
NO
NO163035A
patent/NO118153B/no
unknown

1966-05-17
AT
AT466466A
patent/AT265272B/en
active

1966-05-17
BE
BE681170D
patent/BE681170A/xx
unknown

1966-05-17
BR
BR179514/66A
patent/BR6679514D0/en
unknown

1966-05-17
CH
CH714066A
patent/CH471785A/en
not_active
IP Right Cessation

1966-05-18
DE
DE19661620489
patent/DE1620489A1/en
active
Pending

1970

1970-12-31
MY
MY197048A
patent/MY7000048A/en
unknown

Cited By (1)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

RU2580656C1
(en)

*

2014-11-20
2016-04-10
Закрытое Акционерное Общество “БИОКОМ”
Immediate-release solid dosage form of hydroxychloroquine and method for producing it

Also Published As

Publication number
Publication date

CH471785A
(en)

1969-04-30

NO118153B
(en)

1969-11-17

FR5494M
(en)

1967-10-30

MY7000048A
(en)

1970-12-31

AT265272B
(en)

1968-10-10

BR6679514D0
(en)

1973-10-23

DE1620489A1
(en)

1970-04-30

NL6606704A
(en)

1966-11-21

US3415932A
(en)

1968-12-10

BE681170A
(en)

1966-11-17

Similar Documents

Publication
Publication Date
Title

NL146485B
(en)

1975-07-15

PROCESS FOR THE PREPARATION OF 3-BENZOYL-PHENYLAIC ACID DERIVATIVES CONTAINING PHARMACEUTICAL PREPARATIONS WITH ANTI-INFLAMMATORY ACTION AND FORMED PREPARATIONS OBTAINED BY THE APPLICATION OF THIS PROCESS.

IT1062053B
(en)

1983-06-25

PHARMACEUTICALLY ACTIVE AMMINOGUANIDINE PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT COMMENGOMO

FR1088407A
(en)

1955-03-07

Complex metal salts of sulphonic acids soluble in hydrocarbons, their preparation and applications

NL142684B
(en)

1974-07-15

PROCESS FOR PREPARING PHARMACOLOGICALLY ACTIVE 3-SUBSTITUATED OXAZOLIDINONES-2 AND PHARMACEUTICAL PREPARATIONS PREPARED THEREOF.

GB1107935A
(en)

1968-03-27

A 7-chloro-4-aminoalkylaminoquinoline, its preparation and pharmaceutical compositions

IL35564A0
(en)

1971-01-28

Esters of substituted anthranilic acid,their preparation and pharmaceutical compositions containing them

CH534130A
(en)

1973-02-28

Process for the preparation of new, pharmacologically active nicotinic and anthranilic acid derivatives and of intermediates for the preparation of these active compounds

GB1287602A
(en)

1972-09-06

4,6-DICHLORO-Delta<4.6>-OESTRADIENES

IL30307A0
(en)

1968-09-26

Novel derivatives of acetic acid,their preparation and pharmaceutical compositions containing them

AT280271B
(en)

1970-04-10

Process for the preparation of new coumarinyl-v-triazole oxide derivatives

IL31294A
(en)

1972-08-30

(hexafluoro-3,5-xylyl)-anthranilic acid and its salts,their preparation,and pharmaceutical compositions containing them

PT64998A
(en)

1976-05-01

PROCESS FOR THE PREPARATION OF NEW PHARMACEUTICAL COMPOSITIONS AND COMPOSITIONS OBTAINED THEREBY

NL153084B
(en)

1977-05-16

PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS FOR THE ORAL TREATMENT OF SEBORRHOEA, AND THE PREPARATIONS OBTAINED.

FR2287220A1
(en)

1976-05-07

NEW ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITIONS AND THEIR PREPARATION PROCESS

NL7610260A
(en)

1977-03-22

METHOD FOR THE PREPARATION OF ACTIVE MEDICINAL PRODUCTS FOR ORAL OR ANAL ADMINISTRATION.

AT301055B
(en)

1972-08-25

Process for the preparation of new 6-chloro-11β-methyl-19-norpregna-4,6-diene-3,20-dione and its derivatives

FI52215C
(en)

1977-07-11

Process for the preparation of therapeutically active 1-methyl-2 – (((p-methyl-alpha-phenylbenzyl) oxy) methyl) piperidine and its salts

IL44022A0
(en)

1974-05-16

Novel salts of anti-inflammatory quinoline derivatives,their preparation and pharmaceutical compositions containing them

FR1360488A
(en)

1964-05-08

New coating compositions, in particular insulating varnishes, and their preparation

GB1070310A
(en)

1967-06-01

4-aminoquinoline derivatives

AT281050B
(en)

1970-05-11

Process for the preparation of new phenthiazine derivatives and their acid addition salts

GB1149313A
(en)

1969-04-23

Improvements relating to therapeutically active hydroxychloroquine salts

GB1244665A
(en)

1971-09-02

Pyrazolidine derivatives

FR1525298A
(en)

1968-05-17

Orotic acid derivatives and their preparation

FR3422M
(en)

1965-07-12

The propionates, neutral and basic, of quinine as antifungals and bactericides and pharmaceutical compositions for their administration.

Download PDF in English

None